Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Statins stabilize the renal function of IgA nephropathy.

Moriyama T, Oshima Y, Tanaka K, Iwasaki C, Ochi A, Itabashi M, Takei T, Uchida K, Nitta K.

Ren Fail. 2014 Apr;36(3):356-60. doi: 10.3109/0886022X.2013.866512. Epub 2013 Dec 16.

PMID:
24341619
2.

The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.

Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.

Clin Exp Nephrol. 2004 Sep;8(3):237-42.

PMID:
15480901
3.

Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy.

Buemi M, Allegra A, Corica F, Aloisi C, Giacobbe M, Pettinato G, Corsonello A, Senatore M, Frisina N.

Clin Pharmacol Ther. 2000 Apr;67(4):427-31.

PMID:
10801253
4.

Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers.

Choi S, Lee D, Jeong KH, Moon JY, Lee SH, Lee TW, Ihm CG.

Clin Nephrol. 2009 Nov;72(5):353-9.

PMID:
19863877
5.
7.

Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.

Tanaka K, Moriyama T, Iwasaki C, Takei T, Nitta K.

Clin Exp Nephrol. 2015 Oct;19(5):815-21. doi: 10.1007/s10157-014-1068-9. Epub 2014 Dec 5.

PMID:
25475403
8.

ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.

Woo KT, Lau YK, Wong KS, Chiang GS.

Kidney Int. 2000 Dec;58(6):2485-91.

9.

Statin therapy ameliorates renal allograft function.

Hariparshad SP, Madala ND, Assounga AG.

Transplant Proc. 2009 Dec;41(10):4178-80. doi: 10.1016/j.transproceed.2009.08.075.

PMID:
20005363
10.

Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.

Eitner F, Ackermann D, Hilgers RD, Floege J.

J Nephrol. 2008 May-Jun;21(3):284-9.

PMID:
18587715
11.

Corticosteroid therapy in patients with IgA nephropathy and impaired renal function.

Tamura S, Ueki K, Ideura H, Tsukada Y, Maezawa A, Kawai H, Wakamatsu R, Yano S, Nojima Y, Naruse T.

Clin Nephrol. 2001 Mar;55(3):192-5.

PMID:
11316238
12.

Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.

Moriyama T, Nakayama K, Ochi A, Amemiya N, Tsuruta Y, Kojima C, Itabashi M, Takei T, Uchida K, Nitta K.

Clin Exp Nephrol. 2012 Apr;16(2):231-7. doi: 10.1007/s10157-011-0545-7. Epub 2011 Oct 26.

PMID:
22038185
13.

Reduced pre-pregnancy proteinuria is associated with improving postnatal maternal renal outcomes in IgA nephropathy women.

Oh HJ, Han SH, Yoo DE, Kim SJ, Park JT, Kim JK, Yoo TH, Kang SW, Choi KH.

Clin Nephrol. 2011 Dec;76(6):447-54.

PMID:
22105447
14.

Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy.

Gutiérrez E, González E, Hernández E, Morales E, Martínez MA, Usera G, Praga M.

Clin J Am Soc Nephrol. 2007 Jan;2(1):51-7. Epub 2006 Nov 29.

15.

Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.

Rasche FM, Klotz CH, Czock D, Karges W, Muche R, Jehle PM, Mertz A, Keller F.

Nephron Clin Pract. 2003;93(4):c131-6.

PMID:
12759581
16.

[Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].

Pozzi C, Del Vecchio L, Locatelli F.

G Ital Nefrol. 2002 Sep-Oct;19(5):523-8. Review. Italian.

PMID:
12439840
17.

"Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.

Komatsu H, Fujimoto S, Sato Y, Hara S, Yamada K, Morita S, Eto T.

J Nephrol. 2005 Nov-Dec;18(6):690-5.

PMID:
16358226
18.

Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.

Cruzado JM, Poveda R, Ibernón M, Díaz M, Fulladosa X, Carrera M, Torras J, Bestard O, Navarro I, Ballarín J, Romero R, Grinyó JM.

Nephrol Dial Transplant. 2011 Nov;26(11):3596-602. doi: 10.1093/ndt/gfr072. Epub 2011 Mar 10.

PMID:
21393611
19.

3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the progression of renal dysfunction in Japanese hypertensive patients.

Kuwabara M, Kubo T, Bando K, Hirakawa Y, Kitaoka H, Nishinaga M, Doi YL.

Geriatr Gerontol Int. 2010 Jul;10(3):219-24. doi: 10.1111/j.1447-0594.2010.00584.x. Epub 2010 Feb 4.

PMID:
20141537
20.

Effect of atorvastatin on IgA nephropathy in the rat.

Katzir Z, Leibovitch E, Vaknin H, Schreiber L, Berger E, Matas Z, Fux A, Boaz M, Briliant A, Biro A.

Clin Nephrol. 2013 Mar;79(3):214-20. doi: 10.5414/CN107621.

PMID:
23073067

Supplemental Content

Support Center